St. Michael's Hospital is a teaching hospital and medical centre in Toronto, Ontario, Canada. It was established by the Sisters of St. Joseph in 1892, with the founding goal of taking care of the sick and poor of Toronto's inner city.

There are 463 beds in University of Toronto - St. Michael's Hospital.

During the past decade, University of Toronto - St. Michael's Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Toronto - St. Michael's Hospital" #1 sponsor was "Beth Israel Deaconess Medical Center" with 1 trials, followed by "CSL Behring" with 1 trials sponsored, "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Toronto - St. Michael's Hospital" #1 collaborator was "Biogen" with 1 trials as a collaborator, "Dalhousie University" with 1 trials as a collaborator, "McGill University" with 1 trials as a collaborator, "Medical University of South Carolina" with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "University of Toronto - St. Michael's Hospital" are "Acute Brainstem/Cerebellar Syndrome" (1 trials), "Aneurysmal Subarachnoid Hemorrhage" (1 trials), "Ischemic Stroke" (1 trials), "Multiple Sclerosis" (1 trials) and "Optic Neuritis" (1 trials). Many other conditions were trialed in "University of Toronto - St. Michael's Hospital" in a lesser frequency.

Most popular intervention types in "University of Toronto - St. Michael's Hospital" are "Drug" (4 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Albumin" (1 trials), "CEGSSS-Canadian Endourology Group Stent Symptom Score" (1 trials), "CISC instruction pre-operatively" (1 trials) and "Clazosentan 15 mg/h" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Toronto - St. Michael's Hospital" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Toronto - St. Michael's Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Toronto - St. Michael's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Toronto - St. Michael's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".